CNS Pharmaceuticals (CNSP) Bouncing From 52-Week Low: What Next?

Biopharmaceutical company CNS Pharmaceuticals Inc (NASDAQ: CNSP) is one of the stocks that could be worth tracking by investors at this point due to a key development back in December last year.

The company announced on December 28 that it had been featured in a broadcast from NetworkNewsAudio (NAA). It is a significant development for the stock since NAA is a service that is engaged in providing visibility and brand awareness to the investment community through syndication points distribution.

Related:  Is Sundial Growers (SNDL) On The Verge Of Hitting $2 Mark While Cannabis Industry is Struggling?

It brings the stocks into focus among investors as well and that is the reason why it might be worthwhile to keep the stock on the watch lists at this point.

Earlier on in 2020, the company had announced in September that it chose Image Analysis Group for the role of the imaging partner in its Berucibin clinical trials. IAG is a well-known media agency company and will be engaged in providing key imaging services to the trial.

Related:  Ocugen (OCGN) Soars Suddenly Last Week: Is The Best News To Come?

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.